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Objectives: Hepatitis B virus (HBV) is a member of the hepadnavirus family. The
HBV genome contains four genes designated as S, C, P, and X. The HBV X (HBx)
gene encodes for a 16.5-kDa regulatory protein that enhances HBV replication
and exerts multifunctional activities. The aim of this study is to describe the
rapid and easy purification of HBx using ELP (elastin-like polypeptide) fusion
protein.
Methods: The ELPeHBx fusion protein was overexpressed in Escherichia coli.
Environmental sensitivity was demonstrated via turbidity and dynamic light
scattering as a function of temperature. HBx was purified as an ELP fusion
protein. ELPs are biopolymers of the pentapeptide repeat Val-Pro-Gly-Xaa-Gly
that undergo an inverse temperature phase transition. ELP follows in tempera-
ture and salt consistency, precipitation, and solution repetition (inverse transi-
tion cycling) with polypeptide, where it purifies the protein in a simple manner.
Results: Fusion proteins underwent supramolecular aggregation at 40 C in 1 M
NaCl and slowly resolubilized at subphysiologic temperatures. ELP domain
proteolysis liberated a peptide of comparable size and immunoreactivity to the
commercial HBx.
Conclusion: This study suggests that HBx can be purified rapidly and easily using
inverse transition cycling, and that this method can be applied in determination
of HBx 3D structures and HBx stability study.1. Introduction
In alcohol or virus infection, persistent hepatic
inflammation precedes chronic liver injury. A series of
recent reports strongly indicated that chronicted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventioninflammation is closely linked to the development of
liver cancer, implicating a theory of inflamma-
tionefibrosisecancer axis [1,2]. In Western countries,
the most common cause of liver diseases is alcohol; by
contrast, more than 90% of liver disease cases in Koreareative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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lular carcinoma, which is often initiated by chronic
hepatitis B virus (HBV) or hepatitis C virus infection
and is considered a major worldwide health problem
[3,4]. Approximately 350 million people worldwide are
chronically infected by HBV. In Korea, in particular,
70% of liver cancer cases are caused by HBV infec-
tion, representing a serious national health issue.
HBV contains four genes designated as S, C, P, and
X. As with the rest, the X protein (HBx) encodes a 16.5-
kDa regulatory protein including 154 amino acids. HBx
enhances HBV replication and exerts multifunctional
activities [5]. It acts as a transcriptional coactivator in
the nucleus and stimulates various signal transduction
pathways in the cytoplasm. Recently, HBx is known to
have a kunitz domain, where it performs a special
function as a serine protease inhibitor and transcriptional
activatior [6].
HBx does not bind directly to the DNA but regulates
the activity of cellular proteins such as p53, BubR1, Pin1,
UV-DDB, and HSP40/DanJ to bind directly or indirectly
and contributes to liver cancer progression [7e10].
The objective of this study was to develop an HBx
purification process with elastin-like polypeptide (ELP)
domains. ELPs are genetically engineered poly-
pentapeptide biopolymers like mammalian elastin. They
are composed of pentapeptide repeats of Val-Pro-Gly-
Xaa-Gly, where the guest residue is any amino acid
residue other than proline [11e14]. These polypeptides
are soluble below their characteristic temperature transi-
tion and undergo an abrupt inverse temperature phase
transition to aggregates upon heating and addition of salt.
The hypothesis of this study was that a fusion protein
constructed from ELP and HBx would result in HBx
purification by ELP inverse phase-transitioning
behavior. The ELPeHBx gene was designed, and the
protein product was expressed in Escherichia coli.
Results are presented for HBx purification. This study
suggests that HBx can be purified in a rapid and simple
manner using inverse transition cycling (ITC), and this
method can be applied in determination of HBx 3D
structures and HBx stability study.2. Materials and Methods
2.1. Cloning of full-length HBx gene
To establish the HBx expression construct, poly-
merase chain reaction was performed with the inserting
forward primer (50-AAG CTT CTG GTT CCG CGT
GGA TCC ATG GCT GCT AGG CTG TGC-30) and
reverse primer (50-AAG CTC AGC TAG GCA GAG
GTG AAA AAG TTG CAT GG-30). These resulting
polymerase chain reaction fragments were digested
with HindIII and BlpI, for the purpose of directional and
in-frame ligation to the pQE-His-ELP vector, and
inserted to pQE30-His-ELP (kindly provided byDr. Yoon, Kyonggi University). Expression vectors
containing the fusion gene were transformed into E coli
BL21 (DE3) (Novagen, Madison, WI, USA) for protein
overexpression.
2.2. Overexpression of recombinant fusion
protein
Fifty milliliters of LB and M9 minimum media with
100 mg/ml of ampicillin was inoculated with the
expression strain and induced at a cell density of 0.6
(A600 nm) by the addition of 0.3 mM isopropyl-
thiogalactoside (IPTG) at 3e4 hours.
2.3. Inclusion body purification
Overexpressed cells were harvested by centrifugation
(3200  g for 15 minutes) and resuspended in 5 ml
phosphate-buffered saline (PBS) with lysozme. Cells
were lysed via sonication on ice and centrifuged
(13,000 rpm for 15 minutes, 4 C) to harvest the
inclusion body. The inclusion body pellet was washed
(50 mM PBS, pH 7.4, containing 0.15 M NaCl and
1 mM EDTA) and centrifuged (15 minutes at
13,000 rpm at 4 C). The supernatant was decanted, and
the precipitate was washed in 2 M urea for 20 minutes.
Inclusion bodies were separated by centrifugation at
13,000 rpm for 30 minutes and washed in 0.5% Triton
X-100 (v/v) and 10 mM EDTA (20 minutes incubation
at room temperature). After washing, the inclusion
bodies were recovered by centrifugation at 13,000 rpm
for 15 minutes.
2.4. Inclusion body solubilisation and
purification of recombinant ELPeHBx
Washed inclusion bodies were dissolved in 0.1 M
TriseHCl, pH 8.6, containing 8 M urea for 24 hours at
room temperature. Dissolved ELPeHBx fusion protein
was separated by centrifugation at 13,000 rpm for 30
minutes, and the supernatant was collected. Then,
denaturated fusion protein was dialyzed in 1 M urea
solution. The recombinant ELPeHBx was purified by
three rounds of ITC as described previously [13].
2.5. In vitro degradation of fusion protein
Thrombin (Sigma-Aldrich, St. Louis, MO, USA) was
dissolved in PBS to a concentration of 300 units/ml.
Next, 3 ml of the enzyme solution was added to 100 ml of
a purified ELPeHBx solution in PBS for a final activity
of 0.3 units. The mixture was incubated overnight with
gentle agitation at 37 C, after which sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
was performed as described above.
2.6. Protein analysis
Purified ELPeHBx fusion proteins were separated on
a 12% SDS-PAGE gel and stained with silver. For
Western blotting, ELPeHBx fusion proteins were
separated and transferred onto a polyvinylidene
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appropriate Ab and developed using ECL as a substrate
(GE Healthcare, Pittsburgh, USA).3. Results
3.1. Construction and optimum expression
condition of ELPeHBx
HBx encodes 16.5-kDa proteins which have 154
amino acids with different amino acid sequence between
HBV subtypes. Figure 1 shows the HBx amino acid
sequences in HBV subtypes and the ELPeHBx fusion
protein sequences (Figures 1A and 1B). HBx was
successfully cloned into the modified pQE30(þ)
expression vector, with subsequent adjacent insertion of
ELP genes encoding ELP-(V5G3A2)120 (molecular
weight, 50 kDa) at the protein N terminus (Figure 1C).
HBx expressed following ELP proteins was induced by
IPTG. HBx fusion proteins were successfully expressed
by 0.3 mM IPTG in 3e4 hours in E coli BL21 (DE3)
(Figure 2A).
3.2. Analysis of fusion protein
The expression of ELPeHBx fusion proteins was
checked by SDS-PAGE in soluble and cell debris part.
In the results, the ELPeHBx fusion proteins were in theFigure 1. Hepatitis B virus X (HBx) amino acid sequences and c
of HBx from HBV subtypes (adr, adw). (B) Amino acid sequence
indicate N-terminal 6xHis tag, polypentapeptide, and HBx (adr) pr
expression vector. ELPeHBx fusion proteins expressed adding isocell debris part. This indicates that ELPeHBx was
expressed in the inclusion body (Figure 2B). ELPeHBx
fusion protein was at 70-kDa fragments, which are
comparable in terms of size and immunoreactivity to
commercial his antibody (Figures 2B and 2C).
3.3. Purification of ELPeHBx fusion protein by
ITC
Under optimal expression conditions, 100 ml culture
of IPTG induction was used for purification of
ELPeHBx fusion proteins by ITC [13] (Figure 3A).
ELPeHBx fusion protein was solubilized using 8 M
urea solution, and the soluble protein was diluted to 2
M urea solution in a final concentration for protein
purification. For purification, ELP-HBx fusion proteins
were incubated for 10 minutes at 40 degree celcius in
1 M NaCl and were separated them by centrifugation at
13,000 rpm for 30 min. After centrifugation, the pellet
was incubated in PBS at room temperature for 10
minutes to resolubilize ELP-HBx fusion proteins. SDS-
PAGE revealed the appropriate molecular weight bands
for each protein, with minimal contamination, after
three rounds of ITC (Figures 3B and 3C).
3.4. In vitro degradation of fusion protein
The purified ELPeHBx fusion proteins were cleav-
aged for separation into ELP and HBx using thrombin.onstruction of ELPeHBx. (A) Amino acid sequence alignment
for ELPeHBx fusion protein. The fusion protein sequences
oteins. (C) ELPeHBx fusion construction in modified pQE30
propyl-thiogalactoside controlled T5 promoter.
Figure 2. Expression condition of ELPeHBx fusion protein. (A) Expression of ELPeHBx protein depends on expression time in
0.3 M IPTG concentration. ELPeHBx in BL21 (DE3) strain was cultured until OD600 Z 0.6 and induced by 0.3 M IPTG to
express ELPeHBx recombinant proteins. Collection times were 20 min, 40 min, 1 h, 2 h, 3 h, and 4 h after adding IPTG. (B, C)
Analysis of ELPeHBx fusion protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE) and Western
blotting against anti-his antibody. Arrow indicates the ELPeHBx fusion proteins and ELP cleaved form.
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thrombin and separated into ELP and HBx (using SDS-
PAGE and Western blot), which are comparable in
terms of size (16.5 kDa HBx) and immunoreactivity to
the commercial HBx antibody (Figures 4A and 4B).
4. Discussion
It has been shown previously that HBx protein is
predominantly expressed in the insoluble inclusion body
fraction of the bacterial cell lysate [15e17]. It also tends
to form intracellular aggregates when expressed in
insect cells using a baculovirus expression system [18].
The HBx protein has up to 52% of hydrophobic amino
acids, and the protein contains four disulfide bonds in
a unique arrangement [19]. These structure characteris-
tics may increase HBx protein’s tendency toward
intermolecular aggregation, improper folding, and
accumulation in the inclusion-body fraction. To develop
the process of purifying HBx protein, we used an ELP
purification system to produce HBx protein in an easy
and rapid manner. The protein purification system using
ELP is a powerful system for the expression of HBx
proteins in E coli because the ELP system has an ELP
tag, which can aggregate/dissociate in inverse cycling at
temperature transition of target proteins.A new protein and peptide purification method was
developed that uses ELPs as the purification tag
[13,20].The method of purifying proteins or peptides that
are fused to a stimulus-responsive ELP retains this
behavior in the complex milieu of contaminating cellular
components [21]. Thismethod regulates this phenomenon
by adding salt to the fusion protein solution, and/or by
heating the solution, the phase transition of the ELP fusion
can be triggered in the cell lysate, resulting in the
formation of micron-sized aggregates that are highly
enriched in the ELP fusion, and that can easily be pelleted
by centrifugation. Removing the supernatant, the pellet
containing the fusion protein is in low ionic strength
buffer. Following the resuspension step, insoluble E coli
contaminants trapped in the fusion protein pellet are
removed during centrifugation under conditions of low
temperature and low salt in which the ELP fusion is
soluble. One ITC lasts roughly 30 minutes, and pure
protein is often obtained after three rounds of ITC,making
this process extremely time-efficient and significantly
advantageous compared to affinity purification [21]. This
ELP purification process does not require any resins or
specialized equipment such as a dedicated column.
In this process, we also describe the required removal
of the ELP tag after ELPeHBx purification. The ELP tag
is simply removed after proteolytic cleavage, after which
Figure 3. Inverse transition cycling(ITC) purification of ELPeHBx fusion proteins. (A) Diagram of the ITC method. Soluble
ELPeHBx fusion protein from inclusion bodies in overexpressed Escherichia coli lysate was purified using 8 M Urea. For
purification, ELPeHBx fusion proteins were incubated for 10 min at 40 C in 1 M NaCl and then aggregated. After centrifugation,
the resolubilized pellet was incubated at room temperature for 10 min in phosphate-buffered saline (PBS). The purified ELPeHBx
fusion proteins were cleavaged for separation into ELP and HBx using thrombin. The fusion proteins were successfully digested by
thrombin and separated into ELP and HBx using the ITC method. In the final step, the HBx target proteins are in supernatant. (B)
ITC purification of ELPeHBx target proteins. LysateZ total lysate; inclusion bodies and TritonX100:Zpurification of inclusion
bodies from total lysate; ITC debris Z pellet after ITC; Sup.after ITC Z supernatant after ITC purification. (C) Purified target
proteins. F to F3 are fraction numbers of ELPeHBx fusion proteins after ITC purification.
Figure 4. Thrombin cleavage of purified ELPeHBx fusion proteins. (A) Thrombin cleavage of ELPeHBx fusion proteins by
silver staining after ITC purification and (B) Western blot analysis against anti-HBx antibody. Arrow indicates ELPeHBx fusion
proteins, cleaved ELP proteins, and HBx proteins. 1Z purified ELPeHBx; 2, 3Z thrombin treated ELPeHBx; 4Z purified HBx
after thrombin treatment.
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ELP tag is simply centrifuged out of the solution.
In summary, this study suggests that HBx purification
can be carried out by ELP inverse phase-transitioning
behavior. The ELPeHBx fusion protein product was
expressed in E coli, and HBx can be purified in a rapid
and simple manner using ITC; this method can also be
applied in determination of HBx 3D structures and HBx
stability study.
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